Pharming Group N.V. ADS each representing 10 (PHAR) Financials

$11.23

$-0.23 (-2.01%)

As on 04-Sep-2026 16:00EDT

Market cap

$795 Mln

Revenue (TTM)

$366 Mln

P/E Ratio

80.2

P/B Ratio

2.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	366.45	376.13	297.20	245.32	205.62	198.87
Cost of Revenue	49.36	45.50	35.40	25.21	17.56	21.14
Gross Profit	317.09	330.63	261.80	220.10	188.06	177.73
Operating Expenses	304.74	309.75	265.47	242.39	178.20	158.72
Operating Profit (EBIT)	12.35	20.88	-3.67	-22.29	9.86	19.01
Other Income	--	--	--	--	--	--
Profit before Tax	15.84	12.85	-8.49	-12.01	14.99	23.08
Provision for Tax	6.57	10.31	3.35	-1.46	1.31	7.08
Profit after Tax (Net Income)	9.27	2.85	-11.84	-10.55	13.67	16.00
Minority Interest	--	0.31	--	--	--	--
Consolidated Profit	--	--	--	--	13.67	13.49

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	270.49	277.02	228.91	218.78	204.64	218.71
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	104.25	107.07	108.85	166.11	161.46	178.70
Current Liabilities	93.25	115.79	76.42	77.97	59.70	53.02
Total Liabilities	561.23	499.81	414.18	462.85	425.80	450.44

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	187.30	200.43	125.86	146.51	148.30	167.64
Current Assets	280.69	299.38	288.32	316.34	277.50	282.80
Total Assets	561.23	499.81	414.18	462.85	425.80	450.44
Total Debt*	113.30	115.78	116.30	171.55	166.69	183.39
Net Current Assets	187.44	183.68	204.64	238.37	217.80	178.82

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	54.71	-1.80	-17.30	22.46	37.84
Cash Flow from Investing Activities	--	26.25	31.62	-129.39	5.32	-21.31
Cash from Financing Activities	--	1.50	-34.41	-1.04	-4.98	-27.95
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.13	0.04	-0.02	-0.02	0.20	0.23
Cash EPS ($)	0.14	0.19	0.01	0.01	0.39	0.46
Adjusted Book Value ($)	3.82	3.66	0.34	0.33	2.96	3.12
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.72	0.00	-0.03	0.32	0.54
Free Cash Flow per Share ($)	--	0.71	0.00	-0.03	0.30	0.30

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	0.77	-3.22	-2.77	3.54	4.67
ROE (%)	3.39	1.13	-5.29	-4.98	6.46	8.67
ROA (%)	1.69	0.62	-2.70	-2.37	3.12	4.03
EBIT Margin (%)	8.34	6.27	0.08	-2.47	9.89	14.67
Net Margin (%)	2.53	0.76	-3.98	-4.30	6.65	8.04
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-99.61	0.27	0.21	0.19	0.03	-0.06
EBIT Growth (%)	523.06	9,518.78	104.05	-129.73	-30.25	-41.71
Net Profit Growth (%)	-99.68	124.08	-12.26	-177.14	-14.52	-57.62
EPS Growth (%)	-96.78	3.16	-0.11	-1.08	-0.13	-0.61
Book Value Growth (%)	7.71	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	80.21	469.58	-578.27	-727.19	55.84	39.19
Price / Book Value	2.93	4.83	29.91	35.06	3.73	2.87
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	19.30	36.65	416.17	772.35	21.56	12.15
Close Price ($)	13.89	17.67	10.07	11.43	11.03	8.94
High Price ($)	21.34	18.30	13.20	17.81	13.63	15.52
Low Price ($)	9.54	7.50	6.65	9.65	6.10	7.58
Market Cap ($ Cr)	794.84	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.34	0.42	0.51	0.78	0.81	0.84
Short term debt to equity ratio	0.03	0.03	0.03	0.02	0.03	0.02
Current Ratio	3.01	2.59	3.77	4.06	4.65	5.33
Quick Ratio	2.31	2.03	3.02	3.33	3.94	4.75
Interest Coverage	2.08	2.20	0.03	-1.01	3.80	4.17

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	15.55	14.54	17.48	17.37	12.32	15.73
Asset Turnover	0.67	0.82	0.68	0.55	0.47	0.50
Receivable days	--	51.78	58.11	50.58	50.28	46.40
Inventory Days	--	492.02	590.51	717.74	762.11	417.05
Payable days	--	466.91	136.63	179.46	180.61	169.67
Cash Conversion Cycle	--	76.89	511.99	588.86	631.78	293.78

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.